Clinical Trial Update: Liver Transplantation With Tregs at UCSF [Phase 1, Phase 2]

View source ↗

Summary

A multi-phase clinical trial on liver transplantation involving regulatory T cells (Tregs) at UCSF was terminated, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant

Drugs mentioned

• Tregs (regulatory T cells)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Liver Transplant | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-04-23